Showing 1-4 of 4 results

  • Risk markers for cardiovascular diseases

    Patent application submitted 09 June 2010

    Application Number: 09162329.8 1222

    The invention relates to a method for determining the risk of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method (+).

  • Platelet Stabilization WO/2007/09 8436

    Patent application submitted 07 January 2010

    Application Number: 20100167261

  • Channel Kv1.3 Channel blockers for the treatment of diseases associated with intima layer hyperplasia

    Patent application submitted 08 October 2004

    Application Number: 08105518.8

  • Method and kit for the detection of hypertension risk

    Patent application submitted 29 March 2004

    Application Number: 200400883

    A prognostic or diagnostic method for use in human essential hypertension that detects the presence or absence of a polymorphism in the KCNMB1 gene in a sample taken from a human patient, causing an amino acid substitution in the polymorphism that replaces E (glutamic acid) with K (lysine) in position 65 of the corresponding coded polypeptide. In particular, the polymorphism is a replacement of the unique G nucleotide in position 352 of the KCNMB1 gene sequence with an A nucleotide. Methods, composites, and kits are presented for the diagnosis and prognosis of essential hypertension in humans. Composites are also provided that offer prophylactic or curative treatment of essential hypertension.


An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar